Neurology Letters
Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor
Volume 2, Issue 2, July 2023, Pages 69-77
Bahador Asadi; Sara Hassani; Hossein Ghanaati; Aryobarzan Rahmatian; Mobin Azami; Saeed Amiri Gheshlaghi
Exploring the Potential of Biomarkers for Early Diagnosis and Management of Sporadic Creutzfeldt - Jakob disease; A Review
Volume 2, Issue 2, July 2023, Pages 78-86
Nicholas Aderinto; Gbolahan Olatunji
Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory
Volume 2, Issue 2, July 2023, Pages 87-96
Behnam Ghabel Damirchi; Shima Shakiba; Mohammad Sayadnasiri; Ruhollah Hosseini
Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis
Volume 2, Issue 2, July 2023, Pages 97-105
Fardin Nabizadeh; Nazanin Rafiei; Seyedeh Maryam Vafaei; Mobin Azami; kimia rasouli; Elham Moases Ghaffary; Omid Mirmosayyeb
Escalation or high-efficacy disease-modifying therapies in multiple sclerosis
Volume 2, Issue 2, July 2023, Pages 106-108
Elnaz Asadollahzadeh
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ali Motahharynia; Ahmad Pourmohammadi; Armin Adibi; Vahid Shaygannejad; Fereshteh Ashtari; Iman Adibi; Mehdi Sanayei
Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Amin Najafi; Mohammad Amin Reza; Shirin Shams; Ali Rahmati
Acute disseminated encephalomyelitis (ADEM), Report A Rare Case of Refractory form to treatment (PP-03)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Amin Najafi
Acute disseminated encephalomyelitis following vaccination against SARS-cov-2: a case report (PP-04)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ebrahim Pourakbar
Acute Relapses of Neuromyelitis Optica Spectrum Disorder After COVID-19 Vaccination Shot, Among Iranian Patients (PP-05)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Roshanak Mehdipour; Fereshteh Ashtari
Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mahshid Mahyad; Mohammad Ali Nahayati; Maryam Ebrahimian
Artificial intelligence in multiple sclerosis imaging: advancements, benefits, and challenges (PP-07)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Kimia Kazemzadeh
A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Taraneh Mousavi; Behzad Fatemi; Shekoufeh Nikfar; Mohammad Ali Sahraian
Benign Paroxysmal Positioning Vertigo in Multiple Sclerosis (PP-09)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Fatemeh Jafarlou
Cardiovascular autonomic dysfunction in MS (PP-10)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ashraf Zarvani; Nasim Tabrizi
Case presentation, Atypical imaging of MS (PP-11)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Gholamali Yousefipour
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Neda Ramezani; Elahe Ahmadikhonsaraki; Atoosa Khosravi; Alireza Taghdisi Kashani; Azam Eshaghian-Dorcheh; Zahra Karimi; Saba Naghavi; Ghazal Zandieh; Ahmad Pourmohammadi; Amirhossein Davarpanah Jazi; Iman Adibi
Demyelinating Disease Following Anti-TNFa Treatment (Adalimumab) in Patients with psoriasis: A Case Report (PP-13)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammadreza Malek Zadeh
Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
K. Bahrami; Mohammad Ali Nahayati; Mohammad Shriati
Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammadreza Malek Zadeh; Pourandokht Mousavian; Mohammad Ali Nahayati
Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mehran Rashidi Alavijeh; Saba Naghavi; Neda Ramazani; Sayed Mohsen Hosseini; Iman Adibi
The Effect of Multiple Sclerosis on Peripheral Audio-Vestibular System (PP-17)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Fatemeh Jafarlou
Long-term and Short-term Episodic Memory Dysfunction in Female MS Patients (PP-18)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sara Yazdani; Mohsen Foroughipour
Headache first manifestation of Multiple Sclerosis (PP-19)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Fatemeh Abrishamchi
Investigating the relationship between stress, anxiety and depression with the quality (PP-20)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Majid Jafari; Masoud Lotfizadeh; Razieh Hashemi
)